Revive Therapeutics Ltd. (RVVTF)
USD 0.01
(2.24%)
USD 0.01
(2.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.02 Million | -13.06 Million | -8.3 Million | -2.51 Million | -1.18 Million | -1.49 Million |
| Net Income | -6.32 Million | -17.8 Million | -20.11 Million | -5.38 Million | -1.34 Million | -1.79 Million |
| Depreciation & Amortization | 434.00 | 578.00 | 775.00 | 28.26 Thousand | 3201.00 | 3132.00 |
| Deferred income taxes | - | 28.94 Thousand | 1.55 Million | 1.64 Million | - | - |
| Stock-based compensation | - | 1.03 Million | 8.56 Million | 1.19 Million | 133.23 Thousand | 195.6 Thousand |
| Change in working capital | -747.61 Thousand | 3.54 Million | 705.74 Thousand | -502.98 Thousand | -4848.00 | 93.68 Thousand |
| Other non-cash items | 1.04 Million | 138.41 Thousand | 982.14 Thousand | 502.64 Thousand | 27.38 Thousand | 199.41 Thousand |
| Investing Cash Flow | - | - | -2.71 Million | 142.24 Thousand | -750.68 Thousand | -10.9 Thousand |
| Investments in PPE | - | - | -3 Million | - | -685.00 | -10.9 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -750 Thousand | - |
| Sales/Maturities of investments | - | - | 281.34 Thousand | 142.24 Thousand | - | - |
| Other Investing Activities | - | - | -2718.65 | 142.24 | -750.69 | -9361.00 |
| Financing Cash Flow | 4.19 Million | 376.35 Thousand | 26.24 Million | 3.27 Million | 1.35 Million | 801.16 Thousand |
| Debt repayment | -152.03 Thousand | -151.53 Thousand | -148.99 Thousand | -136.18 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.19 Million | 376.15 Thousand | 28.66 Million | 3.39 Million | 1.35 Million | 801.16 Thousand |
| Other Financing Activities | 152.03 Thousand | 151.73 Thousand | -2.27 Million | 22.86 Thousand | 1350.32 | 801.16 Thousand |
| Accounts receivables | 59.73 Thousand | -45.2 Thousand | 67.5 Thousand | -100.79 Thousand | - | 2456.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -807.34 Thousand | 3.58 Million | 638.23 Thousand | -402.19 Thousand | -4848.00 | 91.23 Thousand |
| Cash at beginning of period | 3.91 Million | 16.59 Million | 1.38 Million | 475.23 Thousand | 1.06 Million | 1.76 Million |
| Cash at end of period | 2.08 Million | 3.91 Million | 16.59 Million | 1.38 Million | 475.23 Thousand | 1.06 Million |
| Capital Expenditure | - | - | -3 Million | - | -685.00 | -10.9 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.82 Million | -12.68 Million | 15.21 Million | 906.24 Thousand | -585.28 Thousand | -708.16 Thousand |
| Free Cash Flow | -6.02 Million | -13.06 Million | -11.3 Million | -2.51 Million | -1.18 Million | -1.5 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.87 Million | -770.62 Thousand | -390.62 Thousand | -1.19 Million | -6.32 Million | -1.94 Million |
| Depreciation & Amortization | 82.00 | 82.00 | 82.00 | 109.00 | 434.00 | 108.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 136.45 | - | - | - | - | - |
| Change in working capital | 75.82 Thousand | -152.42 Thousand | -107.11 Thousand | -239.65 Thousand | -747.61 Thousand | -387.06 Thousand |
| Other non-cash items | 174.49 Thousand | 39.54 Thousand | 2126.00 | 828.71 Thousand | 1.04 Million | 194.2 Thousand |
| Investing Cash Flow | -40 Thousand | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -40 Thousand | - | - | - | - | - |
| Financing Cash Flow | 2.01 Million | - | -38.26 Thousand | 38 Thousand | 4.19 Million | 4.1 Million |
| Debt repayment | -38.77 Thousand | -38.77 Thousand | -38.26 Thousand | -38 Thousand | -152.03 Thousand | -38 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.01 Million | - | - | - | 4.19 Million | 4.1 Million |
| Other Financing Activities | 38.77 Thousand | 38.77 Thousand | 38.26 Thousand | 38 Thousand | 152.03 Thousand | 38 Thousand |
| Accounts receivables | -13.83 Thousand | -31.88 Thousand | -1493.00 | 35.51 Thousand | 59.73 Thousand | -20.02 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 89.65 Thousand | -120.54 Thousand | -105.62 Thousand | -275.16 Thousand | -807.34 Thousand | -367.04 Thousand |
| Cash at beginning of period | 758.41 Thousand | 1.64 Million | 2.08 Million | 2.7 Million | 3.91 Million | 760.17 Thousand |
| Cash at end of period | 1.09 Million | 758.41 Thousand | 1.59 Million | 2.13 Million | 2.08 Million | 2.7 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 340.98 Thousand | -883.41 Thousand | -495.52 Thousand | -568.09 Thousand | -1.82 Million | 1.94 Million |
| Free Cash Flow | -1.63 Million | -883.41 Thousand | -495.52 Thousand | -568.09 Thousand | -6.02 Million | -2.15 Million |
6920
KEYS
HWG
2168
1461
9076